I always enjoy your articles. Juveena went through full Premarket Approval and the pivotal study behind it was randomised and blinded across 15 US centres, with a second look inside the uterus at around eight weeks. In the company's own figures, 61.5% of women who had the hydrogel were adhesion-free at that check, compared with 38.2% after surgery alone. It's starting as a limited release at specialist centres, so I'd love to see the full data once it's published in a journal!!
I always enjoy your articles. Juveena went through full Premarket Approval and the pivotal study behind it was randomised and blinded across 15 US centres, with a second look inside the uterus at around eight weeks. In the company's own figures, 61.5% of women who had the hydrogel were adhesion-free at that check, compared with 38.2% after surgery alone. It's starting as a limited release at specialist centres, so I'd love to see the full data once it's published in a journal!!
It's very hopeful isn't it!